JPWO2022073138A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022073138A5 JPWO2022073138A5 JP2023521536A JP2023521536A JPWO2022073138A5 JP WO2022073138 A5 JPWO2022073138 A5 JP WO2022073138A5 JP 2023521536 A JP2023521536 A JP 2023521536A JP 2023521536 A JP2023521536 A JP 2023521536A JP WO2022073138 A5 JPWO2022073138 A5 JP WO2022073138A5
- Authority
- JP
- Japan
- Prior art keywords
- nanocage
- monomer
- cov
- sars
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089782P | 2020-10-09 | 2020-10-09 | |
| US63/089,782 | 2020-10-09 | ||
| US202163197236P | 2021-06-04 | 2021-06-04 | |
| US63/197,236 | 2021-06-04 | ||
| US202163220929P | 2021-07-12 | 2021-07-12 | |
| US63/220,929 | 2021-07-12 | ||
| PCT/CA2021/051426 WO2022073138A1 (en) | 2020-10-09 | 2021-10-08 | Polypeptides targeting sars-cov-2 and related compositions and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023544211A JP2023544211A (ja) | 2023-10-20 |
| JPWO2022073138A5 true JPWO2022073138A5 (https=) | 2024-10-17 |
| JP2023544211A5 JP2023544211A5 (https=) | 2024-10-17 |
Family
ID=81126329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521536A Pending JP2023544211A (ja) | 2020-10-09 | 2021-10-08 | Ｓａｒｓ－ｃｏｖ－２を標的とするポリペプチドならびに関連する組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250263469A1 (https=) |
| EP (1) | EP4225804A4 (https=) |
| JP (1) | JP2023544211A (https=) |
| KR (1) | KR20230083316A (https=) |
| AU (1) | AU2021356355A1 (https=) |
| BR (1) | BR112023006497A2 (https=) |
| CA (1) | CA3197642A1 (https=) |
| MX (1) | MX2023004023A (https=) |
| WO (1) | WO2022073138A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022212978A1 (en) * | 2021-01-28 | 2023-08-31 | The Hospital For Sick Children | Multabody constructs, compositions, and methods |
| KR20240032875A (ko) * | 2021-07-12 | 2024-03-12 | 더 호스피탈 포 식 칠드런 | 최적화된 멀타바디 작제물, 조성물 및 방법 |
| KR102946895B1 (ko) | 2022-10-21 | 2026-04-02 | 충남대학교산학협력단 | SARS-CoV-2 S1 유래 단백질 및 항체 Fc 영역 단백질을 표면에 동시에 디스플레이하는 페리틴 단백질 구조체 및 이의 코로나바이러스 SARS-CoV-2에 대한 백신 용도 |
| JP2025536337A (ja) * | 2022-10-21 | 2025-11-05 | ザ・ホスピタル・フォー・シック・チルドレン | サルベコウイルスを標的とするマルタボディ構築物、組成物および方法 |
| WO2025231346A1 (en) * | 2024-05-03 | 2025-11-06 | The Wistar Institute Of Anatomy And Biology | Anti-interferon-alpha and anti-interferon-beta antibodies, and methods of use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2780221A1 (en) * | 2009-11-04 | 2011-05-12 | Fabrus Llc | Methods for affinity maturation-based antibody optimization |
| BR112015002091A2 (pt) * | 2012-08-02 | 2017-12-12 | Hoffmann La Roche | método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição |
| WO2015109212A1 (en) * | 2014-01-17 | 2015-07-23 | Pfizer Inc. | Anti-il-2 antibodies and compositions and uses thereof |
| RS59340B1 (sr) * | 2014-11-06 | 2019-10-31 | Hoffmann La Roche | Varijante fc regiona sa modifikovanim vezivanjem za fcrn i metode upotrebe |
| WO2017196847A1 (en) * | 2016-05-10 | 2017-11-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens |
| SG11201900500TA (en) * | 2016-07-22 | 2019-02-27 | Dana Farber Cancer Inst Inc | Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereof |
| WO2019023811A1 (en) * | 2017-08-04 | 2019-02-07 | The Hospital For Sick Children | NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY |
| CR20220552A (es) * | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| CN111592595B (zh) * | 2020-04-27 | 2021-02-19 | 南京医科大学 | 抗新型冠状病毒SARS-Cov-2的中和性抗体及其应用 |
-
2021
- 2021-10-08 MX MX2023004023A patent/MX2023004023A/es unknown
- 2021-10-08 WO PCT/CA2021/051426 patent/WO2022073138A1/en not_active Ceased
- 2021-10-08 US US18/030,944 patent/US20250263469A1/en active Pending
- 2021-10-08 KR KR1020237015177A patent/KR20230083316A/ko active Pending
- 2021-10-08 BR BR112023006497A patent/BR112023006497A2/pt unknown
- 2021-10-08 AU AU2021356355A patent/AU2021356355A1/en active Pending
- 2021-10-08 EP EP21876827.3A patent/EP4225804A4/en active Pending
- 2021-10-08 CA CA3197642A patent/CA3197642A1/en active Pending
- 2021-10-08 JP JP2023521536A patent/JP2023544211A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7337204B2 (ja) | 単鎖可変フラグメントｃｄ３結合タンパク質 | |
| JP2020517287A5 (https=) | ||
| US20170210818A1 (en) | Constant region antibody fusion proteins and compositions thereof | |
| JP2001521496A (ja) | 高い結合活性の多価および多特異的試薬 | |
| JP2018515085A5 (https=) | ||
| CN109071654A (zh) | 靶向Fc受体样5的抗体及使用方法 | |
| IL285101B2 (en) | Antibodies targeting g-protein coupled receptor and methods of use | |
| JP2018502050A5 (https=) | ||
| JP2020505919A5 (https=) | ||
| JP2020500885A5 (https=) | ||
| JP2021512159A5 (https=) | ||
| CN116925215A (zh) | 抗血清白蛋白纳米抗体及其衍生物 | |
| JP2026004299A5 (https=) | ||
| JP2024504777A (ja) | Ｍｕｌｔａｂｏｄｙ構築物、組成物および方法 | |
| JP2025124718A5 (https=) | ||
| JP2019505565A5 (https=) | ||
| CN115461354A (zh) | 用于分子缀合或改造的串联重复癌症靶向肽及其在癌症治疗诊断学中的用途 | |
| JPWO2020014132A5 (https=) | ||
| JPWO2021116182A5 (https=) | ||
| JPWO2022073138A5 (https=) | ||
| JPWO2021139758A5 (https=) | ||
| JP2023550191A (ja) | Ｄｒ４および／またはｄｒ５を標的とするポリペプチドならびに関連する組成物および方法 | |
| JP2023548345A (ja) | クリッピング率の低減した抗原結合ドメイン | |
| JPWO2022104236A5 (https=) | ||
| JPWO2021052349A5 (https=) |